Comparison 3. Amantadine and rimantadine compared to placebo in the prophylaxis of influenza A in the elderly.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 RMT (proved and clinical infection) | 3 | 191 | Risk Ratio (M‐H, Random, 95% CI) | 0.74 [0.13, 4.07] |
2 RMT Monto (100 + 200) and Patriarca | 2 | 103 | Risk Ratio (M‐H, Random, 95% CI) | 0.45 [0.14, 1.41] |
3 RMT 200 | 2 | 75 | Risk Ratio (M‐H, Random, 95% CI) | 0.44 [0.12, 1.63] |
4 RMT 100 | 2 | 130 | Risk Ratio (M‐H, Random, 95% CI) | 1.42 [0.10, 21.10] |